Efficiency of the Imaging Strategy for the Management of Suspected Covid-19

NCT05077228 | Completed

• 1 other identifier: 7976
• Study Type: observational
• Target: 4,000
• Locations: 1 country
• Sites: 1

Brief Summary

Emergency departments have been placed at the heart of the patient triage strategy during the COVID-19 epidemic. In the absence of scientific knowledge on the most efficient strategy to put in place in emergency structures, the centers have proposed very heterogeneous protocols resulting from collaboration with local radiology and virology teams. While the pandemic in France appears to be currently under control, it is important to assess the sorting strategies put in place to deal with a new epidemic.

Conditions

COVID-19

Keywords

COVID-19; SARS-COV-2; Dyspnea; Cough; Sputum; Diarrhea; Confusion

Outcome Measures

Primary Outcomes (1)

• A retrospective study of the imaging strategy for the management of suspected Covid-19

  Files analysed retrospectively from March 09, 2020 to May 08, 2020 will be examined]

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Major subject treated in the emergency rooms of participating centers for suspicion of COVID-19 presenting with fever\> 38 ° and / or respiratory signs (dyspnea, cough, sputum) and / or other symptoms suggestive of COVID-19 (diarrhea , confusion ...) and / or people over 85 or living in an institution during the study period from March 9 to May 8, 2020

You may qualify if:

• Major subject (≥18 years old)
• Subject treated in the emergency rooms of participating centers for suspicion of COVID-19 presenting with fever\> 38 ° and / or respiratory signs (dyspnea, cough, sputum) and / or other symptoms suggestive of COVID-19 (diarrhea , confusion ...) and / or people over 85 or living in an institution during the study period from March 9 to May 8, 2020
• Subject affiliated to a social health insurance protection scheme
• Subject not having expressed their opposition, after information, to the reuse of their data for the purposes of this research

You may not qualify if:

• Subject having expressed opposition to participating in the study
• Subject under guardianship or guardianship
• Subject under safeguard of justice

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Service d'accueil des urgences - Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Location

MeSH Terms

Conditions

COVID-19; Dyspnea; Cough; Diarrhea; Confusion

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Respiration Disorders; Signs and Symptoms, Respiratory; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Signs and Symptoms, Digestive; Neurobehavioral Manifestations; Neurologic Manifestations; Nervous System Diseases

Study Officials

• Sabrina GARNIER KEPKA, MD

  Service d'accueil des urgences - Hôpitaux Universitaires de Strasbourg

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 11, 2021
• First Posted: October 14, 2021
• Study Start: October 1, 2020
• Primary Completion: October 28, 2021
• Study Completion: October 28, 2021
• Last Updated: November 15, 2021

Record last verified: 2021-10

Locations

FR (1)